Introducing the Latest Generation of Low-Throughput Real-Time PCR Instruments

A worldwide exclusive OEM agreement will increase the availability of the latest generation of low-throughput real-time PCR instruments for applications such as nucleic acid quantification, gene expression profiling, and detecting genetic variations.

Roche Applied Science (Basel, Switzerland) has signed an agreement with IT-IS Life Sciences Ltd. (Stokesley, United Kingdom) for the distribution of the new LightCycler Nano Instrument.

The LightCycler Nano is a 32-well format real-time PCR cycler with state of the art functionality and easy-to-use software. As it is both silent and compact, this instrument was designed to be an excellent bench-top companion for laboratory end users performing real-time PCR on a daily basis. The system uses convenient, standard PCR strips and can support all common detection dyes with its full spectrum optics.

Roche is the world's largest biotech company with over 80,000 employees and more than nine billion Swiss francs committed to research and development. Regarding the agreement with IT-IS Life Sciences, Roche's head of PCR projects, Gerd Haberhausen, said, "With the LightCycler Nano Instrument, we now provide a very compact and innovative high performance PCR instrument under a worldwide exclusive agreement. The new LightCycler Nano Instrument delivers proven high quality at an affordable price and expands our qPCR business into a new segment. Customers will love the smart design of the instrument and appreciate the high quality data they can produce with it."

Roderic Fuerst, CEO of IT-IS Life Sciences Ltd., said, "We believe that the creative engineering capability of IT-IS and the market leadership position of Roche in real-time PCR are a perfect match for each other. The LightCycler Nano system will deliver exceptional performance, ease of use, and value due to its highly integrated solid-state design."

Related Links:
Roche Applied Science
IT-IS Life Sciences Ltd.